Linus Pauling Institute

Lytle KA, Jump DB.  2016.  Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible? PLoS One. 11(1):e0146942.

Jump DB, Depner CM, Tripathy S, Lytle KA.  2015.  Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.. Adv Nutr. 6(6):694-702.

Garcia-Jaramillo M, Lytle KA, Spooner MH, Jump DB.  2019.  A Lipidomic Analysis of Docosahexaenoic Acid (22:6, ω3) Mediated Attenuation of Western Diet Induced Nonalcoholic Steatohepatitis in Male Mice.. Metabolites. 9(11)

Jump DB, Depner CM, Tripathy S, Lytle KA.  2016.  Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice.. Proc Nutr Soc. 75(1):1-9.

Tripathy S, Lytle KA, Stevens RD, Bain JR, Newgard CB, Greenberg AS, Huang L-S, Jump DB.  2014.  Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice.. J Lipid Res. 55(7):1448-64.

Lytle KA, Wong CP, Jump DB.  2017.  Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.. PLoS One. 12(4):e0173376.

Lytle KA, Depner CM, Wong CP, Jump DB.  2015.  Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway.. J Lipid Res. 56(10):1936-46.